2023
DOI: 10.1002/adhm.202203302
|View full text |Cite
|
Sign up to set email alerts
|

pH and Thrombin Concentration Are Decisive in Synthesizing Stiff, Stable, and Open‐Porous Fibrin‐Collagen Hydrogel Blends without Chemical Cross‐Linker

Abstract: Fibrin‐collagen hydrogel blends exhibit high potential for tissue engineering applications. However, it is still unclear whether the underlying cross‐linking mechanisms are of chemical or physical nature. It is here hypothesized that chemical cross‐linkers play a negligible role and that instead pH and thrombin concentration are decisive for synthetizing blends with high stiffness and hydrolytic stability. Different fibrin‐collagen formulations (pure and with additional transglutaminase) are used and the blend… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

3
5
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
5

Relationship

2
3

Authors

Journals

citations
Cited by 10 publications
(12 citation statements)
references
References 88 publications
(162 reference statements)
3
5
0
Order By: Relevance
“…Hydrogel Blends Preparation: Fibrin 2.5% (w/v): For the fibrin hydrogel, which was previously described and comprehensively analyzed for the me-chanical properties, [23] a fibrinogen stock solution was prepared by mixing 50 mg mL −1 fibrinogen (from bovine plasma, type I-S, 65-85% protein, Sigma-Aldrich) in PBS at 37 °C for 24 h in a water bath with stirring. The solution was sterilized by filtering through a 0.2 μm sterile syringe filter (Filtropur S, Sarstedt) and stored at −20 °C until use.…”
Section: Methodsmentioning
confidence: 99%
See 2 more Smart Citations
“…Hydrogel Blends Preparation: Fibrin 2.5% (w/v): For the fibrin hydrogel, which was previously described and comprehensively analyzed for the me-chanical properties, [23] a fibrinogen stock solution was prepared by mixing 50 mg mL −1 fibrinogen (from bovine plasma, type I-S, 65-85% protein, Sigma-Aldrich) in PBS at 37 °C for 24 h in a water bath with stirring. The solution was sterilized by filtering through a 0.2 μm sterile syringe filter (Filtropur S, Sarstedt) and stored at −20 °C until use.…”
Section: Methodsmentioning
confidence: 99%
“…Hydrogel blends composed of fibrin and gelatin are proven to promote physiological cellular activity while providing suitable mechanical properties that offer a higher stability during in vitro cultivation. [23,24] Fibrinogen and gelatin are enzymatically cross-linked using microbial transglutaminase at physiological temperature and neutral pH, before the blend is crosslinked with thrombin. [24,25] We hypothesized that fibrin-based hydrogel blends can function as an alternative to collagen I hydrogel in gingival 3D in vitro models due to their amended mechanical properties and improved hydrolytic stability suitable for long-term in vitro cultivation.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…[35] However, since collagen lacks mechanical strength, it is often combined with fibrin gel to produce biofunctional blends with optimal mechanical properties. [27,[34][35][36] A polymerized fibrin gel similar to a physiological clot can be easily synthesized in vitro by mixing fibrinogen with thrombin and calcium chloride (CaCl 2 ). [35,36] For the development of our model, a naturally-derived fibrin-collagen hydrogel blend was used as ECM substitute.…”
Section: Development Of Bioreactors Containing Mesoscopic Vascularize...mentioning
confidence: 99%
“…[27,[34][35][36] A polymerized fibrin gel similar to a physiological clot can be easily synthesized in vitro by mixing fibrinogen with thrombin and calcium chloride (CaCl 2 ). [35,36] For the development of our model, a naturally-derived fibrin-collagen hydrogel blend was used as ECM substitute. Transglutaminase, antifibrinolytics tranexamic acid, and aprotinin were added to improve the mechanical stability of the hydrogel for long-time cultivation under fluid flow and to reduce degradation by resident cells [25,27,37] (Figure S2, Supporting Information).…”
Section: Development Of Bioreactors Containing Mesoscopic Vascularize...mentioning
confidence: 99%